These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9696003)

  • 1. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of endothelin-1, and endothelin A and B receptors in portal hypertensive esophagus of rats.
    Ohta M; Pai R; Kawanaka H; Ma T; Sugimachi K; Sarfeh IJ; Tarnawski AS
    J Physiol Pharmacol; 2000 Mar; 51(1):57-67. PubMed ID: 10768851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of endothelin receptors in the gastric mucosa of portal hypertensive rats.
    Kai S; Bandoh T; Ohta M; Matsumoto T; Tominaga M; Kitano S
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):242-50. PubMed ID: 16460481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced G-protein-induced relaxation in portal hypertensive rats: role of nitric oxide.
    Hou MC; Cahill PA; Zhang S; Redmond EM; Sitzmann JV
    Hepatology; 1997 Jul; 26(1):27-33. PubMed ID: 9214448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
    Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
    Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
    Du QH; Han L; Jiang JJ; Xu Y; Li WH; Li PT; Wang XY; Jia X
    World J Gastroenterol; 2014 Nov; 20(44):16674-82. PubMed ID: 25469036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.
    Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P
    Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
    Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
    Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
    Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
    Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
    Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
    Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
    Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
    Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.